Ascentage Pharma Group International (NASDAQ:AAPG) Stock Price Down 4.6% - Here's WhyMarket Beat·10 hours agoAAPG-3.56%HSBC+1.35%
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer | AAPG Stock NewsStockTitan·1 day ago, 10:30 AMAAPG-3.56%06855+0.18%
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026 | AAPG Stock NewsStockTitan·Jul 26 at 10:30 AMAAPG-3.56%
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Short Interest Down 87.2% in JulyMarket Beat·Jul 25 at 08:20 AMAAPG-3.56%UBS+2.00%
Ascentage Pharma Sets Up US$200 Million Nasdaq ATM Offering Following SEC Shelf FilingTip Ranks·Jul 20 at 07:48 AMAAPG-3.56%06855+0.18%
ASCENTAGE Plans ATM Offering of ADSs in US to Raise Up to USD200 millionAASTOCKS News·Jul 19 at 08:10 PMAAPG-3.56%06855+0.18%
Ascentage Pharma Sets Up $200 Million Nasdaq ATM Offering ProgramTip Ranks·Jul 19 at 06:37 AM06855+0.18%AAPG-3.56%
Ascentage Pharma files for Nasdaq at-the-market ADS offering up to US$200 millionPUBT·Jul 19 at 06:19 AM06855+0.18%AAPG-3.56%
The Divergence of Capital: Value Chain Reconfiguration in 2026Global Report·Jul 17 at 04:12 AMLGCL+5.60%EONR-4.70%
Ascentage Pharma Corrects AGM Date Underpinning Equity Incentive MandateTip Ranks·Jul 13 at 07:48 PM06855+0.18%AAPG-3.56%
Ascentage Pharma corrects AGM date tied to RSU, option grant mandate to May 19, 2025PUBT·Jul 13 at 03:48 PM06855+0.18%AAPG-3.56%
